Siemens Healthineers Receives Strong Investment-Grade Credit Rating
Press release

Siemens Healthineers Receives Strong Investment-Grade Credit Rating

Published on December 12, 2025
  • Moody’s Ratings: Long-term credit rating of A3/outlook stable 
  • Inaugural credit rating marks milestone for Siemens Healthineers financial independence

Siemens Healthineers has received a strong investment-grade credit rating from Moody’s Ratings, marking an important step in the company’s preparations for being financially independent from its majority shareholder, Siemens AG. Awarding its first rating to Siemens Healthineers AG, Moody’s Ratings assigned a long-term credit rating of A3 with outlook stable. This inaugural rating from one of the world’s leading credit-rating agencies will be key when the company comes to seek independent financing in the future. 

“The company has a track record of positive revenue growth on the back of supportive market trends including an aging population, the sophistication of medical treatments and shift towards value-based care driven by increasing digitization and implementation of artificial intelligence features,” wrote Moody’s Ratings. 

Siemens AG, which currently holds around 67% of the outstanding shares in Siemens Healthineers AG, announced on 12 November 2025 its intention to spin off 30% of shares in Siemens Healthineers AG, to deconsolidate Siemens Healthineers AG, and to reduce its shareholding to a financial asset over the medium term. 

“The strong investment-grade credit rating is a testament to our strategic direction and financial framework as well as our operating and financial performance,” said Jochen Schmitz, Siemens Healthineers chief financial officer. “It reflects our resilient profile, underpinned by a high share of recurring revenues and strong cash conversion.”

Download image

Siemens Healthineers 2026

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2025, which ended on September 30, 2025, Siemens Healthineers had approximately 74,000 employees worldwide and generated revenue of around €23.4 billion. Further information is available at siemens-healthineers.com.